Advances in clinical research on glucagon

Area of Science:

• Endocrinology
• Metabolic Research
• Hormone Biology

Background:

• Glucagon, a pancreatic hormone, is traditionally known for its diabetogenic effects, increasing blood glucose through insulin resistance and hepatic gluconeogenesis.
• Emerging research highlights glucagon's critical roles beyond glucose regulation, including significant involvement in hepatic amino acid metabolism.
• Understanding alpha-cell glucagon secretion abnormalities in metabolic disorders as a compensatory mechanism for homeostasis is an active area of investigation.

Purpose of the Study:

• To review recent clinical research advancements concerning the pancreatic hormone glucagon.
• To highlight the impact of new quantitative measurement techniques on understanding glucagon's physiology.
• To synthesize findings on glucagon's roles in glucose and amino acid metabolism, particularly in metabolic dysfunction.

Main Methods:

• This review synthesizes findings from clinical studies and relevant literature.
• It focuses on advances in understanding glucagon's pathophysiology and physiology.
• Key developments include the advent of a quantitative measurement technique for plasma glucagon levels in humans (developed in 2014).

Main Results:

• Clinical research on glucagon lagged due to limitations in precise plasma level measurement techniques.
• A quantitative measurement technique developed in 2014 has enabled a clearer understanding of glucagon secretory dynamics.
• These advancements have elucidated glucagon's complex roles in both glucose and amino acid metabolism in conditions like diabetes.

Conclusions:

• The precise physiology of glucagon secretion in metabolic dysfunction is now better understood thanks to improved measurement technologies.
• Glucagon's functions extend beyond glucose homeostasis to include significant roles in amino acid metabolism.
• Continued research into glucagon is crucial for advancing our understanding and treatment of metabolic disorders.